{"cluster": 58, "subcluster": 2, "abstract_summ": "Key drugs missing clinical trial results include hydroxychloroquine (37.0% completed trials unreported), favipiravir (77.8%) and lopinavir (40.5%).Interpretation: Numerous clinical trials have been registered since the beginning of the COVID-19 outbreak, however, a number of information regarding drugs or trial design were lacking.We included interventional clinical trials focusing on patients with COVID-19 and assessing antiviral drugs or agents.Conclusion: Numerous clinical trials have been registered since the onset of the COVID-19 pandemic.CONCLUSION: Numerous clinical trials have been registered since the onset of the COVID-19 pandemic.", "title_summ": "Covid19db -- An online database of trials of medicinal products to prevent or treat COVID-19, with a specific focus on drug repurposingA brief review of antiviral drugs evaluated in registered clinical trials for COVID-19Missing clinical trial data: the knowledge gap in the safety of potential COVID-19 drugsReview and methodological analysis of trials currently testing treatment and prevention options for the novel coronavirus disease (COVID-19) globally.The race to find a SARS-CoV-2 drug can only be won by a few chosen drugs: a systematic review of registers of clinical trials of drugs aimed at preventing or treating COVID-19Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysisA Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence \u2013 FAST EvidenceAppealing for efficient, well organized clinical trials on COVID-19.Review of trials currently testing treatment and prevention of COVID-19Trials and tribulations: so many potential treatments, so few answers", "title_abstract_phrases": "Interpretation: Numerous clinical trials have been registered since the beginning of the COVID-19 outbreak, however, a number of information regarding drugs or trial design were lacking.Key drugs missing clinical trial results include hydroxychloroquine (37.0% completed trials unreported), favipiravir (77.8%) and lopinavir (40.5%).We included interventional clinical trials focusing on patients with COVID-19 and assessing antiviral drugs or agents.The race to find a SARS-CoV-2 drug can only be won by a few chosen drugs: a systematic review of registers of clinical trials of drugs aimed at preventing or treating COVID-19Considering the massive amount of clinical trial registers aimed to find effective drugs for the prevention and treatment of COVID-19, it is challenging to have a comprehensive view of which drugs are being studied more extensively and when is expected that we will have consistent results regarding their effectiveness.We identified 412 clinical trials registers addressing the effect of pharmacological treatments on COVID-19, predominantly from Asia and Europe (42.2% and 31.1% of clinical trials registers, respectively)."}